Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma

Clinical trial NCT06384248 · UNKNOWN

Trial details

NCT number: NCT06384248
Sponsor: Letolab
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable or Metastatic Sarcoma

Start date: 2024-04-26
Primary completion: 2025-12-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.